Michael Green (January 20, 1954 – February 10, 2023) was an American molecular biologist and cell biologist at the University of Massachusetts Medical School, where he was the chair of the Department of Molecular, Cell and Cancer Biology, director of the UMass Cancer Center, and a Howard Hughes Medical Institute investigator.
[1][5] He worked as a postdoctoral fellow with Thomas Maniatis, then at Harvard University, before joining the faculty there in 1984.
[4] Green was a co-founder of a Cambridge, Massachusetts-based biotechnology company called Fulcrum Therapeutics.
The group also studies the effects of regulatory patterns on the behavior of cancer cells, using genome-wide RNA interference screens to identify genes involved in cell proliferation or apoptosis in the context of oncogenic mutations.
[1][5] In 2014, Green began studying the rare genetic disease Rett syndrome.